BG50995A1 - Platinum cytostatic - Google Patents

Platinum cytostatic

Info

Publication number
BG50995A1
BG50995A1 BG82504A BG8250488A BG50995A1 BG 50995 A1 BG50995 A1 BG 50995A1 BG 82504 A BG82504 A BG 82504A BG 8250488 A BG8250488 A BG 8250488A BG 50995 A1 BG50995 A1 BG 50995A1
Authority
BG
Bulgaria
Prior art keywords
platinum
cis
cytostatic agent
cytostatic
platinum cytostatic
Prior art date
Application number
BG82504A
Other languages
English (en)
Inventor
Frantisek Kiss
Eduard Hajek
Zdenka Uhrova
Ivanka Zavodna
Monika Bohuminska
Jindrich Borak
Jiri Novotny
Ludmila Marcikova
Jaroslav Salamoun
Original Assignee
Lachema Op
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=5447844&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG50995(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lachema Op filed Critical Lachema Op
Publication of BG50995A1 publication Critical patent/BG50995A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electroplating And Plating Baths Therefor (AREA)
  • Developing Agents For Electrophotography (AREA)
BG82504A 1986-12-29 1988-01-04 Platinum cytostatic BG50995A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS8610074A CS269719B1 (en) 1986-12-29 1986-12-29 Platinum cytostatic

Publications (1)

Publication Number Publication Date
BG50995A1 true BG50995A1 (en) 1993-01-15

Family

ID=5447844

Family Applications (1)

Application Number Title Priority Date Filing Date
BG82504A BG50995A1 (en) 1986-12-29 1988-01-04 Platinum cytostatic

Country Status (9)

Country Link
EP (1) EP0275559B1 (xx)
JP (1) JPS63239292A (xx)
AT (1) ATE64740T1 (xx)
BG (1) BG50995A1 (xx)
CS (1) CS269719B1 (xx)
DE (1) DE3771057D1 (xx)
ES (1) ES2040240T3 (xx)
FI (1) FI88165C (xx)
IL (1) IL85029A (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8901433A (nl) * 1989-06-06 1991-01-02 Pharmachemie Bv Carboplatinpreparaat.
JPH06287021A (ja) * 1992-04-22 1994-10-11 Tanaka Kikinzoku Kogyo Kk 光学活性な白金錯化合物の光学的分割方法
WO1995020956A1 (en) * 1994-02-07 1995-08-10 Kiss Laboratories S.R.O. Anti-tumour medical preparation on the basis of carboplatin and the method of its production
CZ292170B6 (cs) * 1998-08-14 2003-08-13 Pliva-Lachema A.S. Farmaceutická kompozice s protinádorovým účinkem na bázi carboplatiny
CN1121380C (zh) 2000-03-03 2003-09-17 北京兴大豪斯科技有限公司 一种抗肿瘤的双二羧酸二氨络铂衍生物及其药物组合物
DE10306761B9 (de) * 2003-02-17 2004-12-23 Völkl, Klaus Peter, Dr. Verfahren zur Herstellung von sterilen pharmazeutischen Wirkstoffen
HUE056897T2 (hu) 2015-12-09 2022-03-28 Univ Wien Med Monomaleimid-funkcionalizált platinavegyületek rákterápiához

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH588505A5 (xx) * 1972-06-08 1977-06-15 Research Corp
US4302446A (en) * 1979-10-02 1981-11-24 Bristol-Myers Company Pharmaceutical compositions
IL76889A0 (en) * 1984-11-02 1986-02-28 Johnson Matthey Plc Solubilised platinum compound,method for the production thereof and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
ATE64740T1 (de) 1991-07-15
EP0275559B1 (en) 1991-06-26
FI875729A (fi) 1988-06-30
ES2040240T3 (es) 1993-10-16
IL85029A0 (en) 1988-06-30
FI88165C (fi) 1993-04-13
CS1007486A1 (en) 1989-10-13
CS269719B1 (en) 1990-05-14
DE3771057D1 (de) 1991-08-01
FI88165B (fi) 1992-12-31
FI875729A0 (fi) 1987-12-28
EP0275559A1 (en) 1988-07-27
JPS63239292A (ja) 1988-10-05
IL85029A (en) 1992-06-21

Similar Documents

Publication Publication Date Title
CA2041260A1 (en) Ultrasonic contrast agents, processes for their preparation and the use thereof as diagnostic and therapeutic agents
CA2124932A1 (en) Sex steroid activity inhibitors
MY115339A (en) Compositions containing micronized nebivolol
ZA844585B (en) 2-pyrimidinyl-1-piperazine derivatives,processes for their preparation and medicaments containing them
JO1502B1 (en) New pharmacy vehicles
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
GEP19971265B (en) Substituted sulphonamides,, the substituted cyclic amines in the form of intermediate compounds for reception of the substituted sulphonamides and the pharmaceutical composition on the basis of the substituted sulphonamides displaying activity towards thromboxane receptors
ATE99302T1 (de) Substituierte flavonoide verbindungen, ihre salze, ihre herstellung und die enthaltende arnzeizusammensetzungen.
IL94433A0 (en) Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
MY101784A (en) Novel pharmacological compounds
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
IL107870A0 (en) Pharmaceutical compositions having antidepressant activity comprising pramipexol
ES8207169A1 (es) Un procedimiento para la preparacion de nuevos derivados de piperazinilquinazolina y de homopiperazinilquinazolina hi- pertensora con acticidad.
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
HUT38097A (en) Process for preparing substituted benzopyrans and pharmaceutical compositions containing them as active substances
IL85029A0 (en) Platinum cytostatic agent
HUT46837A (en) Compositions of insectifuge and acarifuge activity containing alpha, omega-amino-alkohol derivatives as active components and process for producing the active components
ES473754A1 (es) Procedimiento de preparacion de composiciones farmaceuticas a base de nuevas w-tiopropinamidas, y de sus sales con una base mineral y organica
ES8705763A1 (es) Procedimiento para preparar nuevas formulaciones de gel parafines terapeuticos y diagnosticos
FR2378518A1 (fr) Nouveaux medicaments a base de derives de tetrahydrodibenzopyranne
DE3780191D1 (de) Octahydroindolizine analgesica und 7-keto-zwischenprodukte.
FR2355846A1 (fr) Esters de penicillines utilisables comme medicaments
ES2096559T3 (es) Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso.
EP0043976A3 (en) Anti-tumor agent
JO1711B1 (en) Therapeutic agents